Literature DB >> 15333856

Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis.

C Pinet1, P Scillia, M Cassart, M Lamotte, C Knoop, C Mélot, M Estenne.   

Abstract

BACKGROUND: In the absence of complications, recipients of lung transplants for cystic fibrosis have normal pulmonary function but the impact of the procedure on the strength and bulk of respiratory and limb muscles has not been studied.
METHODS: Twelve stable patients who had undergone lung transplantation for cystic fibrosis 48 months earlier (range 8-95) and 12 normal subjects matched for age, height, and sex were studied. The following parameters were measured: standard lung function, peak oxygen uptake by cycle ergometry, diaphragm surface area by computed tomographic (CT) scanning, diaphragm and abdominal muscle thickness by ultrasonography, twitch transdiaphragmatic and gastric pressures, quadriceps isokinetic strength, and quadriceps cross section by CT scanning, and lean body mass. Diaphragm mass was computed from diaphragm surface area and thickness.
RESULTS: Twitch transdiaphragmatic and gastric pressures, diaphragm mass, and abdominal muscle thickness were similar in the two groups but quadriceps strength and cross section were decreased by nearly 30% in the patients. Patients had preserved quadriceps strength per unit cross section but reduced quadriceps cross section per unit lean body mass. The cumulative dose of corticosteroids was an independent predictor of quadriceps atrophy. Peak oxygen uptake showed positive correlations with quadriceps strength and cross section in the two groups, but peak oxygen uptake per unit quadriceps strength or cross section was reduced in the patient group.
CONCLUSIONS: The diaphragm and abdominal muscles have preserved strength and bulk in patients transplanted for cystic fibrosis but the quadriceps is weak due to muscle atrophy. This atrophy is caused in part by corticosteroid therapy and correlates with the reduction in exercise capacity.

Entities:  

Mesh:

Year:  2004        PMID: 15333856      PMCID: PMC1747142          DOI: 10.1136/thx.2004.021766

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  46 in total

Review 1.  Skeletal muscle dysfunction in lung transplantation.

Authors:  A C Krieger; P Szidon; S Kesten
Journal:  J Heart Lung Transplant       Date:  2000-04       Impact factor: 10.247

Review 2.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

3.  Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis.

Authors:  S L Elkin; L Williams; M Moore; M E Hodson; O M Rutherford
Journal:  Clin Sci (Lond)       Date:  2000-10       Impact factor: 6.124

4.  Effect of preoperative hyperinflation on static lung volumes after lung transplantation.

Authors:  C Pinet; M Estenne
Journal:  Eur Respir J       Date:  2000-09       Impact factor: 16.671

5.  Exercise performance in cystic fibrosis before and after bilateral lung transplantation.

Authors:  D A Oelberg; D M Systrom; D H Markowitz; S L Zorb; C Wright; J C Wain; L C Ginns
Journal:  J Heart Lung Transplant       Date:  1998-11       Impact factor: 10.247

6.  Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation.

Authors:  L C Lands; A A Smountas; G Mesiano; L Brosseau; H Shennib; M Charbonneau; R Gauthier
Journal:  J Heart Lung Transplant       Date:  1999-02       Impact factor: 10.247

7.  Peripheral muscle weakness and exercise capacity in children with cystic fibrosis.

Authors:  K de Meer; V A Gulmans; J van Der Laag
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

8.  Muscle size and cardiorespiratory response to exercise in cystic fibrosis.

Authors:  C Moser; P Tirakitsoontorn; E Nussbaum; R Newcomb; D M Cooper
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

9.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.

Authors:  S Bernard; P LeBlanc; F Whittom; G Carrier; J Jobin; R Belleau; F Maltais
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

10.  Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients.

Authors:  G B Tirdel; R Girgis; R S Fishman; J Theodore
Journal:  J Heart Lung Transplant       Date:  1998-12       Impact factor: 10.247

View more
  6 in total

1.  Can pretransplant computed-tomographic assessment predict outcomes after lung transplantation?

Authors:  Seiichiro Sugimoto
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  The evidence regarding exercise training in the management of cystic fibrosis: a systematic review.

Authors:  Michael J Shoemaker; Heather Hurt; Leah Arndt
Journal:  Cardiopulm Phys Ther J       Date:  2008-09

3.  Skeletal muscle strength and endurance in recipients of lung transplants.

Authors:  Sunita Mathur; Robert D Levy; W Darlene Reid
Journal:  Cardiopulm Phys Ther J       Date:  2008-09

4.  Sarcopenia of thoracic muscle mass is not a risk factor for survival in lung transplant recipients.

Authors:  Seokkee Lee; Hyo Chae Paik; Seok Jin Haam; Chang Young Lee; Kyung Sik Nam; Hee Suk Jung; Young Woo Do; Jee Won Shu; Jin Gu Lee
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

5.  The effect of steroid administration on fetal diaphragm function.

Authors:  Fatma Ozdemir; Gokhan Acmaz; Yusuf Madendag; Ilknur Col Madendag; Iptisam Ipek Muderris
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-12       Impact factor: 3.105

6.  The effect of whole body vibration exposure on muscle function in children with cystic fibrosis: a pilot efficacy trial.

Authors:  Kaitlin O'Keefe; Rhonda Orr; Peite Huang; Hiran Selvadurai; Peter Cooper; Craig Frank Munns; Maria A Fiatarone Singh
Journal:  J Clin Med Res       Date:  2013-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.